HSD17B1 Antibody

1. Our genetic study demonstrated HSD17B1 937 G variant as a risk factor for infertility in women with stage I and II endometriosis in Polish Caucasian patients. PMID: 28405865
2. HSD17B1 is a promising marker to predict EC prognosis. PMID: 27923582
3. Macronutrient intakes were associated with serum estradiol level, and these associations may be modified by HSD17B1 polymorphism in postmenopausal Japanese women. PMID: 28980890
4. the effect of 17beta-HSD1 expression on breast cancer cell transcript profile in steroid-deprived condition, was investigated. PMID: 27544780
5. Mutation in the 17-beta-hydroxysteroid dehydrogenase gene is associated with congenital adrenal hyperplasia. PMID: 28207417
6. Substrate inhibition of 17beta-HSD1 in tumor epithelial cells and regulation of 17beta-HSD7 by 17beta-HSD1 knockdown has been demonstrated. PMID: 28554725
7. 10 natural products were evaluated leading to inhibition of the activity of 17beta-HSD1 at the concentration of 25 muM, and six of them inhibit the activity over 50%. PMID: 27933483
8. The structure of human 17beta-HSD1 and biological function have been studied extensively in the last two decades. In humans, the enzyme is expressed in placenta, ovary, endometrium and breast; high activity of estrogen activation provides the basis of 17beta-HSD1's implication in estrogen-dependent diseases, such as breast cancer, endometriosis and non-small cell lung carcinomas. [Review] PMID: 27102893
9. These findings suggested that the HSD17B1 Ser312Gly polymorphism might confer genetic cancer susceptibility in an ethnic-dependent manner, especially among Caucasians. PMID: 26923943
10. The rs605059 polymorphism of the HSD17B1 gene is associated with increased risk of recurrent spontaneous abortion. PMID: 25394609
11. Review/Meta-analysis: HSD17B1 rs605059 polymorphisms were not associated with the risks of endometrial cancer or endometriosis. PMID: 26261478
12. the HSD17B1 transcript and protein were identified in HeLa, SiHa, Ca Ski and C-33A cervical cancer cells. PMID: 26054693
13. Increased expression of HSD17B1 in NSCLC may contribute to an elevated intratissue level of E2 and consequently may support the development and spread of cancer. PMID: 25564397
14. The key enzymes of ovarian steroidogenesis, CYP 19 and 17beta-HSD, are active in the ovaries of postmenopausal women. PMID: 24855493
15. 17beta-HSD1 and 17beta-HSD7 are principal reductive 17beta-hydroxysteroid dehydrogenases and major players in the viability of estrogen-dependent breast cancer cells. PMID: 25257817
16. E1-induced ERELuc activity in the inhibitor-treated uterus was reduced by the HSD17B1 inhibitor. PMID: 25617485
17. Single nucleotide polymorphism in HSD17B1 gene is associated with hepatocellular carcinoma. PMID: 24563232
18. Onset of epileptiform discharges is modestly delayed in slices from ovariectomized rats replaced with physiologically relevant doses of EB, but the number of discharges is not affected. PMID: 24113171
19. results demonstrated that HSD17B1 expression and its ability to convert the weak estrogen E1 to the more potent E2 can be associated with DNA methylation in the 5' flanking region in GC cells. PMID: 23916544
20. analysis of intratumoral localization and activity of 17beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer PMID: 23837683
21. We found the presence of HSD17B1 transcripts and proteins in human Jurkat acute T cell leukemia, Hut-78 and Raji B lymphoma cells PMID: 23540283
22. HSD17B1-mediated decreased conversion of estrone to estradiol may reduce the estrogenic effects, thereby reducing the risk of developing breast cancer during long-term hormone replacement therapy use. [Meta-analysis] PMID: 23430226
23. study demonstrated that 17beta-HSD1 increases breast cancer cell migration, in spite of its positive regulation of the antimetastatic gene NM23 PMID: 22691413
24. In this review, the results suggest that HSD17B1 and PR polymorphism may play a role in the risk of endometriosis PMID: 22613790
25. Frequencies of rs605059 AA genotype and A allele were significantly increased in Chinese patients with uterine leiomyoma compared to healthy controls. PMID: 22546946
26. Data suggest that HSD17B1 is overexpressed in endometrial cancer tissue; HSD17B1 appears responsible for shift toward reductive metabolism (i.e., greater reduction of estrone to 17-beta-estradiol; lesser oxidation of 17-beta-estradiol to estrone). PMID: 22362820
27. Breast cancer cells T47D, MCF-7, BT 20, and JEG 3 as control cells, were chosen to evaluate the contribution of 17beta-hydroxysteroid dehydrogenase type 1 and type 2 to the estradiol/estrone ratio. PMID: 22253796
28. reduced HSD17B1 expression can be associated with DNA methylation in the 5' flanking region of HSD17B1 in CRC from the proximal colon. PMID: 22176788
29. HSD17B1 gene may contribute to sex steroid-mediated effects on colorectal cancer development. PMID: 21317201
30. SNPs (HSD17B1 (rs2010750, rs598126 and rs676387), COMT (rs4680), UGT1A1 (rs8175347) and ESR1 (rs9340799)) seem to be related to mammographic density in the same direction of their associations with breast cancer risk PMID: 22199302
31. Data show that in 17beta-HSD1 inhibitors are placed in the substrate-binding site and they occupy an apolar subpocket consisting of the following amino acids: Gly94, Leu95, Leu96, Asn152, Tyr155, and Phe192. PMID: 21857977
32. HSD17B1 upregulation by sodium butyrate is associated with increased conversion of E1 to E2 in colorectal cancer cells. PMID: 21563966
33. Obese women with selected CYP19 and 17-beta HSD gene variants had remarkably different E2 trajectories around the the final menstrual period, resulting in different postmenopausal E2 levels. PMID: 21198743
34. Genetic variants in ESR1, ESR2, and HSD17B1 genes could modify susceptibility to endometriosis and might influence the fertility status in endometriosis patients. PMID: 20586553
35. This study suggests that HSD17B1 312Gly allele may be a protective factor for breast cancer development in Caucasians. PMID: 20151320
36. CYP17 (T1931C) and HSD17beta1 (A1954G) polymorphisms may jointly increase the risk of breast cancer. PMID: 20193327
37. genetic assiciation studies [Japan, Brazil]: data suggest SNP in 17beta-HSD1 gene may modify association between dietary isoflavone intake & breast cancer PMID: 20432167
38. 17beta-HSD1 up-regulates breast cancer cell growth by a dual action on estradiol synthesis and dihydrotestosterone inactivation. PMID: 20172961
39. A significant increment of 17beta-HSD1 followed exemestane neoadjuvant therapy of postmenopausal ER-positive breast carcinoma. This may represent the compensatory response of breast carcinoma tissues to estrogen depletion. PMID: 20151319
40. An amino acid important for steroid/retinoid discrimination was identified and its significance was highlighted by the results of molecular modeling studies. PMID: 20382160
41. Data report structures of the binary and ternary complexes of 17beta-HSD1 with a new inhibitor E2B, opening a new orientation of breast cancer treatment. PMID: 19929851
42. increased activity in hypothalamic obesity PMID: 12519880
43. possible hypothalamic mediators regulating adipose tissue 11 beta-HSD-1 might include down-regulation by CRH, ACTH, and alpha 2 sympathetic stimulation, and up-regulation by beta 2 sympathetic stimulation and by the cytokines TNFalpha and IL-1 beta PMID: 12519881
44. examination of amplification in breast cancer PMID: 12527905
45. Evidence for association between the Ser312Gly polymorphism in HSD17B1 and endometriosis was found in a Japanese population PMID: 15640252
46. the germline variants in HSD17B1 characterized by htSNPs do not substantially influence the risk of prostate cancer in U.S. and European whites PMID: 16311626
47. Corticotrophin-releasing hormone (CRH) increased whereas alpha-helical CRH decreased the mRNA levels of STS, CYP19A1, and HSD17B1, the key enzymes for estrogen synthesis. PMID: 16467490
48. HSD17B1 is a multispecific enzyme. PMID: 16480815
49. importance of 17HSD type 2 in breast cancer- & non-tumour breast cell lines; high or low expression affected oestradiol concentration significantly; response dependent on endogenous expression of 17HSD type 1 which seems to be dominant to 17HSD type 2 PMID: 16954436
50. These results suggest that soy consumption may interact with polymorphisms in the 17beta-HSD1 gene in relation to endometrial cancer risk. PMID: 17301695

显示更多

收起更多

HGNC: 5210

OMIM: 109684

KEGG: hsa:3292

STRING: 9606.ENSP00000466799

UniGene: Hs.654385